Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Oral Oncol. 2014 Sep 18;50(11):1072–1080. doi: 10.1016/j.oraloncology.2014.08.015

Table 3.

Comparison of survival estimates per 1% methylation of the 7 CpG loci identified from the oral rinse Infinium HumanMethylation450 BeadArray to the corresponding estimates from the pyrosequencing data set.

Locus ID Infinium HumanMethyaltion450 BeadArray
Pyrosequencing
Crude HR (95% CI) Adjusted HR* (95% CI) Crude HR (95% CI) Adjusted HR* (95% CI)
cg02319972 0.87 (0.82, 0.92) 0.85 (0.80, 0.91) 1.00 (0.92, 1.09) 1.01 (0.91, 1.11)

cg03784083 0.74 (0.65, 0.85) 0.70 (0.60, 0.82) 0.95 (0.87, 1.04) 0.96 (0.82, 1.12)

cg15740054 3.65 (2.09, 6.32) 6.31 (3.05, 13.05) 1.00 (0.76, 1.33) 0.91 (0.66, 1.24)

cg18928362 1.72 (1.32, 2.25) 1.60 (1.22, 2.12) 0.84 (0.21, 3.40) 0.36 (0.07, 1.77)

cg21022792 0.85 (0.79, 0.92) 0.84 (0.77, 0.91) 0.94 (0.76, 1.15) 0.78 (0.61, 1.01)

cg21702497 1.48 (1.23, 1.79) 1.54 (1.20, 1.98) 1.00 (0.17, 5.79) 0.79 (0.09, 7.21)

cg25914931 3.24 (1.86, 5.66) 4.45 (2.17, 9.15) 1.03 (0.17, 6.23) 0.53 (0.08, 3.51)
*

Adjusted for age, gender, smoking pack-years, HPV16 and stage at diagnosis